Yi Wang

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Kidney Transplantation

Immune Response

Top Venues

Cell biology international

Journal of cellular and molecular medicine

The journal of gene medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Shiwei Liu, Yang Yu, Jie Xu, Yi Wang, Deng Li
Single-cell and bulk RNA-sequencing reveals mitosis-involved gene HAUS1 is a promising indicator for predicting prognosis and immune responses in prostate adenocarcinoma (PRAD). Cell biology international 48 (8) (2024)
Shiwei Liu, Yang Yu, Jie Xu, Yi Wang, Deng Li
Single-cell and bulk RNA-sequencing reveals mitosis-involved gene HAUS1 is a promising indicator for predicting prognosis and immune responses in prostate adenocarcinoma (PRAD). Cell biology international 48 (8) (2024)
Shiwei Liu, Yang Yu, Jie Xu, Yi Wang, Deng Li
Single-cell and bulk RNA-sequencing reveals mitosis-involved gene HAUS1 is a promising indicator for predicting prognosis and immune responses in prostate adenocarcinoma (PRAD). Cell biology international (2024)
Yaoyu Yu, Guihua Chen, Chao Jiang, Tuanjie Guo, Heting Tang, Zhihao Yuan, Yi Wang, Xiangyin Tan, Jinyuan Chen, Encheng Zhang, Xiang Wang
USP31 serves as a potential biomarker for predicting prognosis and immune responses for clear cell renal cell carcinoma via single-cell and bulk RNA-sequencing. The journal of gene medicine (2023)
Yi Wang, Xinyu Zhang, Guihua Chen, Qianwei Xing, Bingye Zhu, Xiang Wang
Integrated analyses reveal the prognostic, immunological features and mechanisms of cuproptosis critical mediator gene FDX1 in KIRC. Genes and immunity (2023)
Yi Wang, Hao Ji, Bingye Zhu, Qianwei Xing, Huyang Xie
Molecular subtypes based on metabolic genes are potential biomarkers for predicting prognosis and immune responses of clear cell renal cell carcinoma. European journal of immunology (2022)
Gang Wang, Fangfang Qu, Shouyong Liu, Jincai Zhou, Yi Wang
Nucleolar protein NOP2 could serve as a potential prognostic predictor for clear cell renal cell carcinoma. Bioengineered 12 (1) (2021)
Deng Li, Shiwei Liu, Jie Xu, Lei Chen, Chaoliang Xu, Feiteng Chen, Zijie Xu, Yu Zhang, Shujie Xia, Yi Shao, Yi Wang
Ferroptosis-related gene CHAC1 is a valid indicator for the poor prognosis of kidney renal clear cell carcinoma. Journal of cellular and molecular medicine 25 (7) (2021)
Qianwei Xing, Tengyue Zeng, Shouyong Liu, Hong Cheng, Limin Ma, Yi Wang
A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma. BMC cancer 21 (1) (2021)
Hong Cheng, Bin Xu, Lijie Zhang, Yi Wang, Ming Chen, Shuqiu Chen
Bortezomib alleviates antibody-mediated rejection in kidney transplantation by facilitating Atg5 expression. Journal of cellular and molecular medicine 25 (23) (2021)
Qianwei Xing, Chengjian Ji, Bingye Zhu, Rong Cong, Yi Wang
Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma. Cancer medicine 9 (19) (2020)